GlaxoSmithKline
Last updated on 2013-11-22T06:52+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| british rival | 50.00% | EN | 02/02/2007 |
| candidate | 50.00% | EN | 15/11/2005 |
| Names | Lang | Count |
|---|---|---|
| GlaxoSmithKline | EN | 22.94% |
| GlaxoSmithKline | FR | 8.56% |
| GlaxoSmithKline | PT | 5.87% |
| GlaxoSmithKline | ES | 5.26% |
| GlaxoSmithKline | DE | 5.20% |
| GlaxoSmithKline | AF | 5.20% |
| GlaxoSmithKline | PL | 5.20% |
| GlaxoSmithKline | TR | 5.20% |
| GlaxoSmithKline | NN | 5.20% |
| GlaxoSmithKline | RU | 5.20% |
| GlaxoSmithKline | NO | 5.20% |
| GlaxoSmithKline | UK | 5.20% |
| GlaxoSmithKline | HR | 5.20% |
| GlaxoSmithKline | AR | 5.20% |
| Glaxo Smith Kline | EN | 0.98% |
| GLAXOSMITHKLINE | EN | 0.90% |
| Glaxo Smith Kline | FR | 0.90% |
| Glaxo Smith Kline | SV | 0.84% |
| Glaxo-Smith-Kline | DE | 0.53% |
| GlaxoSmithKline | SA | 0.39% |
| Glaxo Smithkline | ES | 0.29% |
| Glaxo Smithkline | EN | 0.29% |
| Glaxo Smith Klein | EN | 0.12% |
| Glaxo SmithKline | EN | 0.10% |
| GLAXOSMITHKLINE | FR | 0.06% |
| Glaxo Smithkline | FR | 0.02% |
| GLAXOSMITHKLINE | SA | 0.02% |
| Pharmakonzern Glaxo Smithkline | DE | 0.00% |
| 葛蘭素史克 | ZH | 0.00% |
| Pharmariesen Glaxo Smith Kline | DE | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Pfizer Inc | 4.07% |
| Inc | 3.56% |
| World Health Organization | 2.75% |
 | British | 2.24% |
| GlaxoSmithKline Plc | 2.04% |
| Novartis | 1.93% |
| European Union | 1.43% |
| Eli Lilly | 1.43% |
| Reuters Group | 1.32% |
| Wall Street | 1.22% |
| Drug Administration | 1.22% |
| Commission | 1.12% |
| Pharmaceuticals Inc | 1.12% |
| Abbott Laboratories | 1.02% |
| Bristol Myers Squibb | 0.71% |
| Chinese company | 0.71% |
| Boehringer Ingelheim | 0.71% |
| Takeda Pharmaceutical | 0.61% |
| Dr Reddy | 0.61% |
| US firm | 0.61% |
| CNBC | 0.61% |
| Association | 0.61% |
| Health Organisation | 0.61% |
| National Health | 0.61% |
| United Nations | 0.61% |
| Jaguar Cars | 0.51% |
| Capital Economics | 0.51% |
| Land Rover | 0.51% |
| Berkshire Hathaway | 0.51% |
| Mark Haefele | 0.51% |
| Type | Entity Name | Score |
|---|---|---|
| Pfizer Inc | 0.0399 |
| Peter van der Velden | 0.0385 |
| Andrew McCracken | 0.0303 |
| GlaxoSmithKline Plc | 0.0199 |
| Novartis | 0.0185 |
| Bisco Misr | 0.0167 |
| Josef Penninger | 0.0164 |
| Eli Lilly | 0.0135 |
| Pharmaceuticals Inc | 0.0105 |
| Drug Administration | 0.0096 |
| Abbott Laboratories | 0.0096 |
| Inc | 0.009 |
| Bristol Myers Squibb | 0.0071 |
| Boehringer Ingelheim | 0.007 |
| Chinese company | 0.0066 |
| Takeda Pharmaceutical | 0.006 |
| Dr Reddy | 0.006 |
| Michael Macaluso | 0.006 |
| US firm | 0.0059 |
| Key Findings | 0.0052 |
| Mahendra Patel | 0.0051 |
| Mark Haefele | 0.005 |
| Jack Allen | 0.005 |
| Cadila Healthcare | 0.005 |
| Teva Pharmaceuticals | 0.005 |
| Grey Group | 0.005 |
| Capital Economics | 0.0049 |
| Land Rover | 0.0048 |
| Berkshire Hathaway | 0.0048 |
| Roche Holding AG | 0.0048 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Thursday, February 27, 2020
1:51:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 